Biomarker Driven Patient Selection Using Almac PNPLA3 & HSD17B13 Clinical Trial Assays

Time: 11:40 am
day: Conf Day 1 Track 2 AM

Details:

  • Overview of the PNPLA3 & HSD17B13 Almac Clinical Trial Assays
  • Assay Design & Analytical Specifications
  • Implementation of the PNPLA3 or HSD17B13 assay in your MASH / MAFLD trial & expected performance

Speakers: